224 related articles for article (PubMed ID: 18359048)
1. Predicting the potential impact of a cytotoxic T-lymphocyte HIV vaccine: how often should you vaccinate and how strong should the vaccine be?
Smith RJ; Schwartz EJ
Math Biosci; 2008 Apr; 212(2):180-7. PubMed ID: 18359048
[TBL] [Abstract][Full Text] [Related]
2. Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location.
Masopust D
J Intern Med; 2009 Jan; 265(1):125-37. PubMed ID: 19093965
[TBL] [Abstract][Full Text] [Related]
3. Modeling the population level effects of an HIV-1 vaccine in an era of highly active antiretroviral therapy.
Rida W; Sandberg S
Bull Math Biol; 2009 Apr; 71(3):648-80. PubMed ID: 19214640
[TBL] [Abstract][Full Text] [Related]
4. Mathematical study of a staged-progression HIV model with imperfect vaccine.
Gumel AB; McCluskey CC; van den Driessche P
Bull Math Biol; 2006 Nov; 68(8):2105-28. PubMed ID: 16868850
[TBL] [Abstract][Full Text] [Related]
5. Pulse HIV vaccination: feasibility for virus eradication and optimal vaccination schedule.
Yang Y; Xiao Y; Wu J
Bull Math Biol; 2013 May; 75(5):725-51. PubMed ID: 23535904
[TBL] [Abstract][Full Text] [Related]
6. The dual role of CD4 T helper cells in the infection dynamics of HIV and their importance for vaccination.
Altes HK; Wodarz D; Jansen VA
J Theor Biol; 2002 Feb; 214(4):633-46. PubMed ID: 11851372
[TBL] [Abstract][Full Text] [Related]
7. Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines.
Robinson HL; Weinhold KJ
J Infect Dis; 2006 Dec; 194(12):1625-7. PubMed ID: 17109331
[No Abstract] [Full Text] [Related]
8. Rates of HIV immune escape and reversion: implications for vaccination.
Davenport MP; Loh L; Petravic J; Kent SJ
Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018
[TBL] [Abstract][Full Text] [Related]
9. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever?
Egan MA
Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741
[No Abstract] [Full Text] [Related]
10. Global stability for a class of virus models with cytotoxic T lymphocyte immune response and antigenic variation.
Souza MO; Zubelli JP
Bull Math Biol; 2011 Mar; 73(3):609-25. PubMed ID: 20464520
[TBL] [Abstract][Full Text] [Related]
11. Analysis of antiretroviral immunotherapy trials with potentially non-normal and incomplete longitudinal data.
Mogg R; Mehrotra DV
Stat Med; 2007 Feb; 26(3):484-97. PubMed ID: 16625520
[TBL] [Abstract][Full Text] [Related]
12. Immune control.
Fornataro K; Jefferys R
Body Posit; 1999 Mar; 12(3):9-12. PubMed ID: 11366299
[TBL] [Abstract][Full Text] [Related]
13. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
Belyakov IM; Ahlers JD
Trends Immunol; 2008 Nov; 29(11):574-85. PubMed ID: 18838298
[TBL] [Abstract][Full Text] [Related]
14. What's new in HIV/AIDS. Protective immunity in HIV infection: where do we stand?
Draenert R; Goebel FD
Infection; 2004 Aug; 32(4):250-2. PubMed ID: 15293085
[TBL] [Abstract][Full Text] [Related]
15. A boost for the immune system.
TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365925
[TBL] [Abstract][Full Text] [Related]
16. Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes.
Yang OO
AIDS; 2008 Jan; 22(3):325-31. PubMed ID: 18195558
[No Abstract] [Full Text] [Related]
17. [Development of an AIDS vaccine: status report].
Girard MP
Med Trop (Mars); 2007 Aug; 67(4):340-6. PubMed ID: 17926791
[TBL] [Abstract][Full Text] [Related]
18. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
[TBL] [Abstract][Full Text] [Related]
19. [HIV vaccination].
Jablonowski H
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():68-9. PubMed ID: 19031568
[No Abstract] [Full Text] [Related]
20. Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV.
White A
Med Hypotheses; 2008 Dec; 71(6):909-13. PubMed ID: 18768264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
